Regulatory Guide 2026

IFRS S2 for Health & Pharma in Mexico: 2026 Guide

IFRS S2 is the climate-specific standard adopted by CNBV as mandatory for all BMV and BIVA issuers starting January 2025, making Mexico the first country in North America to implement IASB's ISSB standards. Companies must report GHG emissions across all three scopes, conduct climate scenario analysis, and disclose how climate change impacts their strategy and financial model. Limited assurance of the report by an external auditor will be required starting with the 2027 reporting cycle.

The pharmaceutical/health sector is the only one in Mexico with specific sectoral environmental regulation (NOM-087 RPBI) that must integrate with the 30 IBSO indicators of NIS B-1 — a sector where CINIF and SEMARNAT regulate the same waste stream with different formats and reporting deadlines.

Why IFRS S2 Applies Differently in Health & Pharma

CFO and Sustainability Director of BMV-listed healthcare and pharmaceutical companies

Companies in this sector:Genomma LabMédica SurHospital ABCFEMSA Salud

Biological-Infectious Hazardous Waste (RPBI) — classification, weight, and final disposal required by NOM-087-SEMARNAT/SSA1-2002 that must align with NIS B-1 hazardous waste indicators

Pharmaceutical cold chain — energy consumption of refrigeration chambers at -2°C to -8°C and ultra-freezing at -80°C without sub-metering by product type or batch

Scope 3 Cat 1 for imported active pharmaceutical ingredients (APIs) — suppliers in India/China without carbon footprint data per API or production batch

Medical gases (nitrous oxide N2O — potent GHG with GWP 298) used in anesthesia without recovery systems in Mexican hospitals

Critical IFRS S2 KPIs for Health & Pharma

Required KPI	Data Source	Difficulty
RPBI generated per occupied bed-day (kg/bed-day)	Purchased electricity (Scope 2)	High 🔴
Energy consumption per equivalent surgical procedure (kWh/procedure)	Electricity bills (Scope 2)	High 🔴
Water intensity per hospital bed or per pharmaceutical product unit	Cat 1 - APIs e ingredientes farmacéuticos importados	High 🔴
Percentage of pharmaceutical waste with certified final disposal (%)	HR / payroll system	Medium 🟡
N2O emissions per anesthetic procedure (kgCO2e/procedure)	ERP / accounting system	Medium 🟡

Hard-to-Collect Data in Health & Pharma

RPBI weight by category (infectious, pathological, sharps, pharmaceutical) — many Mexican hospitals do not disaggregate by category for NIS B-1 reporting

N2O consumption in anesthetic procedures per operating room (requires integration with medical gas management system)

Emission factor of imported APIs by supplier/country of origin for Scope 3 Cat 1

That is why manual Excel-based processes will not pass the 2027 assurance. Without automated traceability, an external auditor cannot verify the completeness or accuracy of emissions data.

Checklist: 8 Steps to Comply with IFRS S2 in Health & Pharma

1
Reporting of GHG emissions Scope 1, 2, and 3 (full value chain) in metric tons of CO₂ equivalent
2
Climate scenario analysis aligned to TCFD using at least 1.5°C and 2°C as reference pathways
3
Identification and quantification of physical risks (chronic and acute) and transition risks
4
Disclosure of emissions reduction targets, including net-zero goals with interim milestones
5
Description of how climate risks and opportunities affect business model, strategy, and cash flows
6
Connect data sources (ERP, meters, suppliers) to a centralized platform
7
Review with internal audit team and adjust consolidation perimeter
8
Generate report in CNBV/CINIF format ready for external assurance

How Climatta Automates IFRS S2 for Health & Pharma

Automated Collection

Eliminate spreadsheets in Health & Pharma. Climatta connects your systems and automatically collects RPBI generated per occupied bed-day and other critical KPIs.

Auditor-Grade Traceability

Every data point has source, date, and owner documented. The 2027 assurance auditor can trace every figure to its origin in your systems.

IFRS S2 Report Ready

Generates the report in the exact CNBV format — tables, metrics, and narrative. No last-minute manual reformatting.

Onboarding in 4 Weeks

Climatta connects to Health & Pharma systems in 4 weeks. No months-long IT project or external implementation consultant.

FAQ: IFRS S2 in Health & Pharma

Yes. The pharmaceutical/health sector is the only one in Mexico with specific sectoral environmental regulation (NOM-087 RPBI) that must integrate with the 30 IBSO indicators of NIS B-1 — a sector where CINIF and SEMARNAT regulate the same waste stream with different formats and reporting deadlines.

The first report covers FY2025 and must be submitted in 2026 to CNBV. Aseguramiento limitado requerido desde 2027.

IFRS S2 requires: Reporting of GHG emissions Scope 1, 2, and 3 (full value chain) in metric tons of CO₂ equivalent; Climate scenario analysis aligned to TCFD using at least 1.5°C and 2°C as reference pathways; Identification and quantification of physical risks (chronic and acute) and transition risks. For Health & Pharma, the most critical are: RPBI generated per occupied bed-day (kg/bed-day), Energy consumption per equivalent surgical procedure (kWh/procedure), Water intensity per hospital bed or per pharmaceutical product unit.

Issuers that fail to submit the IFRS S2 report to CNBV in 2026 face formal observations, potential suspension of stock exchange operations, and reputational damage with ESG investors. Aseguramiento limitado requerido desde 2027.

With Climatta, typical onboarding for Health & Pharma takes 4–8 weeks: 2 weeks connecting to existing systems, 2 weeks validating historical data, and 2–4 weeks generating the pilot report in CNBV format.

Ready to comply with IFRS S2 in Health & Pharma?

Climatta centralizes all data collection, generates the report in regulatory format, and leaves it ready for 2027 external assurance. No spreadsheets.